769 - Histoplasmosis, Blastomycosis, Coccidioidomycosis and the Immunocompromised Host - Risk Assessment

Speaker(s)

• 

  Ella J. Ariza Heredia, MD

  Associate Professor
  The University of Texas MD Anderson Cancer Center
  Houston, TX, United States

  Disclosure: Disclosure(s): Merck & Co. Inc: Grant/Research Support (Ongoing)